Medical Breakthroughs
Cardiac AI: Why FDA Clearance Doesn’t Guarantee Low CAC
For investors looking at cleared cardiac monitoring assets, the path from a regulatory green light to…
Medical Breakthroughs
For investors looking at cleared cardiac monitoring assets, the path from a regulatory green light to…
Medical Breakthroughs
The data on Butterfly Network is solid, fiscal 2025 revenue hit $97.6 million, a 19% year-over-year…
Medical Breakthroughs
In healthcare AI, the investment game is no longer about who raises the most capital. It’s…
Medical Breakthroughs
Everyone loves to talk about the size of the funding round in healthcare AI, with headlines…
Medical Breakthroughs
The whole conversation around healthcare AI exits has changed. The speculative gold rush is over, and…
Medical Breakthroughs
When a new AI medical device gets FDA clearance, it’s easy to get excited. For investors…
Medical Breakthroughs
Healthcare AI investing is full of hidden traps. Everyone gets fixated on clinical validation, FDA pathways,…
Medical Breakthroughs
For founders and investors deep in the cardiac AI world, the liquidity question is always there.…
Medical Breakthroughs
When you’re pricing a diagnostic AI, especially one fighting for reimbursement, its clinical efficacy and technological…
Medical Breakthroughs
2024 and 2025 were the years healthcare AI finally got its public market test, with Tempus…